Dáil Éireann Debate, Tuesday - 3 November 2020
1184. Deputy Cian O'Callaghan asked the Minister for Health if his attention has been drawn to a report (details supplied); if so, if he has considered the findings of the report; if similar measures are being considered here; and if he will make a statement on the matter. [32548/20]
View answerThe issues and risks associated with the use of sodium valproate by women of childbearing age are well recognised by medicines regulators and healthcare professionals in Ireland. I am aware of the recent publication of the Independent Medicines and Medical Devices Safety Review in the UK, and have agreed to meet relevant patient groups later this month to discuss this and other issues relating to sodium valproate.
